patent/WO-2007004231-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31fde909f1fe9467faa13972d1d41b30
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
filingDate	2005-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a84e849661eba84941ab36eb8733bda4
publicationDate	2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-2007004231-A1
titleOfInvention	Hiv-1 vaccinogens with immunomodulators
abstract	Vaccinagens comprise recombinant plasmid vaccine constructs NK-29692CO, NK-49426CO, NK-49587CO, NK-IND-tat-CO and NK-IND-nef-CO and recombinant viral vector vaccine constructs VV-29692CO, VV 49426CO, VV 49587CO, VV-IND-tatCO and VV-IND-nefCO.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2094296-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2094296-A2
priorityDate	2005-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004052909-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1335023-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005016378-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413498 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128139163 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5447130

Total number of triples: 24.